|
gptkbp:instanceOf
|
gptkb:Company
|
|
gptkbp:acquisition
|
gptkb:Gavis_Pharmaceuticals
gptkb:Mr._Vikram_S._Sharma
gptkb:Merck_KGaA's_generics_business
|
|
gptkbp:advertising
|
gptkb:Mr._Anil_S._Joshi
gptkb:Ms._Neelam_S._Singh
gptkb:Mr._Deepak_S._Agarwal
gptkb:Dr._Neha_S._Gupta
gptkb:Mr._Anil_Kumar
gptkb:Mr._Anil_S._Kumar
gptkb:Mr._Ashok_K._Mehta
gptkb:Mr._Rohan_S._Mehta
Mr. Prakash S. Rao
Mr. Rajesh K. Sharma
Mr._Sanjay_Gupta
|
|
gptkbp:awards
|
Pharma_Company_of_the_Year_2020
Best_Company_in_India_2021
|
|
gptkbp:businessModel
|
gptkb:Mr._Kunal_S._Agarwal
|
|
gptkbp:CEO
|
gptkb:Mr._Sanjay_S._Nair
Kedar_Upadhye
|
|
gptkbp:clinicalTrials
|
gptkb:Dr._Sanjay_K._Mehta
conducts numerous clinical trials
|
|
gptkbp:community
|
gptkb:Ms._Neelam_K._Sharma
|
|
gptkbp:customerService
|
gptkb:Ms._Priya_S._Nair
|
|
gptkbp:employees
|
over 20,000
|
|
gptkbp:evaluates
|
gptkb:Mr._Anil_K._Gupta
|
|
gptkbp:founded
|
1968
|
|
gptkbp:founder
|
gptkb:Desh_Bandhu_Gupta
|
|
gptkbp:governance
|
gptkb:Mr._Prakash_K._Iyer
|
|
gptkbp:headCoach
|
gptkb:Dr._Ritu_S._Sharma
gptkb:Mr._Suresh_K._Iyer
|
|
gptkbp:headquarters
|
gptkb:Mumbai
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Lupin India
|
|
gptkbp:internationalCooperation
|
gptkb:Mr._Ramesh_S._Gupta
|
|
gptkbp:market
|
approximately $10 billion
Mr._Rajiv_S._Nair
|
|
gptkbp:operates_in
|
over 100 countries
|
|
gptkbp:operations
|
gptkb:Mr._Ramesh_K._Iyer
|
|
gptkbp:partnerships
|
gptkb:AstraZeneca
gptkb:Mylan
gptkb:Bristol-Myers_Squibb
gptkb:Hikma_Pharmaceuticals
|
|
gptkbp:products
|
generic drugs
biologics
branded drugs
|
|
gptkbp:regulatoryCompliance
|
gptkb:Ms._Kavita_S._Sharma
gptkb:Ms._Kavita_K._Sharma
gptkb:Mr._Raghavendra_S._Rao
|
|
gptkbp:research
|
gptkb:Dr._Ramesh_Swaminathan
|
|
gptkbp:researchAndDevelopment
|
focus on chronic diseases
focus on anti-infectives
focus on cardiovascular diseases
focus on diabetes
|
|
gptkbp:revenue
|
$2.1 billion (2021)
|
|
gptkbp:riskManagement
|
gptkb:Mr._Raghav_K._Mehta
|
|
gptkbp:social_responsibility
|
gptkb:Mr._Ramesh_K._Iyer
|
|
gptkbp:stockExchange
|
gptkb:BSE
NSE
|
|
gptkbp:subsidiary
|
gptkb:Lupin_Pharmaceuticals,_Inc.
Lupin Limited, UK
Lupin_Australia_Pty_Ltd.
|
|
gptkbp:supplyChain
|
gptkb:Mr._Vikram_S._Joshi
|
|
gptkbp:sustainability_initiatives
|
focus on ethical practices
focus on environmental responsibility
focus on community health
focus on employee welfare
|
|
gptkbp:tactics
|
Mr._Raghav_S._Iyer
|